Back to search results

OBWELL: Psychotherapy for Postpartum Depression

This study, called OBWELL, is testing two types of talk therapy, Cognitive Behavioral Therapy (CBT) and Interpersonal Therapy (IPT), to help women with Postpartum Depression (PPD). PPD is a type of depression that happens after childbirth and can cause intense symptoms that last longer than the "baby blues." The study aims to see how well these therapies work to reduce PPD symptoms after four weeks. You may be able to join if you are a mother of a baby in the NICU, are over 18, speak English, gave birth between 24 hours and 12 months ago, and have symptoms of depression.

Study design
This interventional study plans to enroll 72 women. It is testing two types of psychotherapy.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your depression symptoms will be measured at 4 weeks after starting psychotherapy.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06991166

OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression

Recruiting
NAAges 18+InterventionalTreatment
Hackensack Meridian Health
~72 participants
Updated 2026-02-11 on ClinicalTrials.gov
What's tested:Cognitive behavioral therapy (CBT) psychotherapy group/telehealthInterpersonal therapy (IPT) psychotherapy group/telehealth

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Post Partum Depression post initial psychotherapy
Measured over At 4 weeks

Conditions

Post Partum Depression

Explore related trials

Postpartum Depression

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Yeraz Markarian, PhD · PRINCIPAL_INVESTIGATOR · Hackensack Meridian Health

Who to contact

Melissa Giuliano, LMSW
[email protected]
5519964450
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Mother of NICU infant
Older than age 18
English-speaking
Gave birth more than 24 hours ago and less than 12 months prior to enrollment
Depression as assessed by:

Exclusion

A diagnosis of Substance Dependency or Substance Use
Acute suicidal or infanticidal ideation
Current psychosis
Medical history of cognitive impairment
Infant death of current NICU admission
Marked non-compliance with intervention (e.g, non-attendance of more than one session during a 4-week intervention or failure to complete study assessments),
Are in medical treatment that would prevent participation (i.e., medical treatment that requires inpatient hospitalization and thus would prevent participation of study visits.)

What this trial measures

  • Post Partum Depression post initial psychotherapyAt 4 weeks

    Quantitative assessment of treatment effectiveness in reducing PPD symptoms will be conducted with the Edinburgh Postnatal Depression Scale (EPDS), a 10-item validated self-report scale. Total scores on the EPDS range from 0 to 30, with scores 13 and above indicating depressive illness, or a high risk of developing a depressive disorder. The measures will be administered at the following timepoints: Week 0 Baseline: At study entry prior to starting group psychotherapy in the Outpatient Behavioral Health practice Week 4: After completing the first 4-week intervention of the two-intervention sequence, prior to "crossing over"